×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
EPRX – eupraxia pharmaceuticals inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
EPRX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/4
10:20 pm
eprx
Analysts See More Than 77% Upside for Eupraxia Pharmaceuticals (EPRX), Here's Why [Yahoo! Finance]
Medium
Report
Analysts See More Than 77% Upside for Eupraxia Pharmaceuticals (EPRX), Here's Why [Yahoo! Finance]
11/17
05:56 am
eprx
Individual investors account for 43% of Eupraxia Pharmaceuticals Inc.'s (TSE:EPRX) ownership, while institutions account for 26% [Yahoo! Finance]
Low
Report
Individual investors account for 43% of Eupraxia Pharmaceuticals Inc.'s (TSE:EPRX) ownership, while institutions account for 26% [Yahoo! Finance]
11/4
05:28 pm
eprx
Eupraxia Pharmaceuticals Reports Third Quarter 2025 Financial Results [Canadian Business Journal (Canada)]
Medium
Report
Eupraxia Pharmaceuticals Reports Third Quarter 2025 Financial Results [Canadian Business Journal (Canada)]
11/4
04:39 pm
eprx
Eupraxia Pharmaceuticals Reports Third Quarter 2025 Financial Results
Medium
Report
Eupraxia Pharmaceuticals Reports Third Quarter 2025 Financial Results
10/30
07:50 am
eprx
Eupraxia Pharmaceuticals (NASDAQ:EPRX) was upgraded by analysts at Leede Financial to a "strong-buy" rating.
Low
Report
Eupraxia Pharmaceuticals (NASDAQ:EPRX) was upgraded by analysts at Leede Financial to a "strong-buy" rating.
10/14
08:11 pm
eprx
Wall Street Analysts Believe Eupraxia Pharmaceuticals Inc. (EPRX) Could Rally 85.12%: Here's is How to Trade [Yahoo! Finance]
Medium
Report
Wall Street Analysts Believe Eupraxia Pharmaceuticals Inc. (EPRX) Could Rally 85.12%: Here's is How to Trade [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/14
04:45 pm
eprx
Form SCHEDULE 13G/A EUPRAXIA PHARMACEUTICALS Filed by: DISBROW ROBERT
Low
Report
Form SCHEDULE 13G/A EUPRAXIA PHARMACEUTICALS Filed by: DISBROW ROBERT
11/14
09:11 am
eprx
Form SCHEDULE 13G EUPRAXIA PHARMACEUTICALS Filed by: Beutel, Goodman & Co Ltd.
Low
Report
Form SCHEDULE 13G EUPRAXIA PHARMACEUTICALS Filed by: Beutel, Goodman & Co Ltd.
11/13
12:15 pm
eprx
Form SCHEDULE 13G EUPRAXIA PHARMACEUTICALS Filed by: MANCHESTER MANAGEMENT CO LLC
Low
Report
Form SCHEDULE 13G EUPRAXIA PHARMACEUTICALS Filed by: MANCHESTER MANAGEMENT CO LLC
11/4
04:01 pm
eprx
Form 6-K EUPRAXIA PHARMACEUTICALS For: Nov 04
Medium
Report
Form 6-K EUPRAXIA PHARMACEUTICALS For: Nov 04
10/1
10:57 am
eprx
Form 6-K EUPRAXIA PHARMACEUTICALS For: Sep 29
Low
Report
Form 6-K EUPRAXIA PHARMACEUTICALS For: Sep 29
9/29
04:33 pm
eprx
Form 6-K EUPRAXIA PHARMACEUTICALS For: Sep 29
Low
Report
Form 6-K EUPRAXIA PHARMACEUTICALS For: Sep 29
9/26
09:20 pm
eprx
Form SCHEDULE 13D/A EUPRAXIA PHARMACEUTICALS Filed by: Freedman Joseph S.
Low
Report
Form SCHEDULE 13D/A EUPRAXIA PHARMACEUTICALS Filed by: Freedman Joseph S.
9/24
11:12 am
eprx
Form 6-K EUPRAXIA PHARMACEUTICALS For: Sep 24
Low
Report
Form 6-K EUPRAXIA PHARMACEUTICALS For: Sep 24
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: